Taxotere Class Action Lawsuit

taxotere-alopecia-patientThe class action lawyers at Phillips Law Group are reviewing potential lawsuits involving Taxotere® (generic name: docetaxel) and permanent hair loss.

If you or someone you love suffers from excessive and permanent hair loss after taking the cancer drug Taxotere, contact us immediately for a free review of your case.

You may be entitled to join a Taxotere class action lawsuit and receive financial compensation for your pain and suffering.  

Call or text 1-800-706-3000 or fill out our online form for a FREE Case Review.

Taxotere and Permanent Hair Loss

Taxotere is a cancer drug commonly used to treat breast cancer. The drug has also been used to treat certain forms of lung, stomach, neck and prostate cancers.

The drug was first approved by the U.S. Food and Drug Administration (FDA) in 1996, shortly after it was manufactured by the Sanofi Aventis Pharmaceutical Company.

Over the past ten years, numerous scientific studies have shown a link between Taxotere and permanent hair loss.

In 2006, a study conducted by Denver, Colorado, oncologist Dr. Scot Sedlacek found that more than six percent of all breast cancer patients failed to grow back half of their hair after taking Taxotere for cancer treatment.

This form of permanent hair loss is known as alopecia.

A 2010 study published in the Journal of the American Academy of Dermatology suggested Taxotere was to blame for an increasing number of patients suffering from permanent, chemotherapy-induced alopecia.

And in 2013, the National Cancer Research Institute published a study that showed ten to 15 percent of all cancer patients who took Taxotere suffered from permanent, irreversible hair loss.

If you suffer from permanent baldness after taking the cancer drug Taxotere, contact the knowledgeable Taxotere class action lawsuit attorneys at Phillips Law Group today. We can help you recover the maximum amount of compensation allowed by law for your permanent injury.

Call or text 1-800-706-3000 or fill out our FREE Case Review Form

Contact Our Taxotere Class Action Lawsuit Attorneys Today

Sanofi Aventis is being investigated for failing to warn patients about the elevated risk of permanent, irreversible hair loss associated with the defective drug Taxotere.

Although hailed as a breast cancer “wonder drug,” many patients feel that Taxotere should have come with a warning regarding its known ability to cause permanent baldness.

Had patients been rightfully informed of all of Taxotere side effects, they could have made the decision to take another cancer medication that was equally as effective as Taxotere, yet did not carry the risk of permanent hair loss.

While hair loss may seem like a small price to pay for an extension on life, living with alopecia can make survivors feel as though they have not yet conquered the disease. This is unfair and unjust, and our compassionate Taxotere class action lawsuit attorneys are here to help all Taxotere victims through this difficult time.

Contact us today at 1-800-706-3000 or fill out our FREE Case Review Form to discuss your Taxotere class action lawsuit options.

 

 

Back to Top